Welcome to Paid Research Studies




  • Condition:   Alcohol Use Disorder
    Interventions:   Device: Active rTMS;   Device: Sham rTMS
    Sponsor:   VA Office of Research and Development
    Not yet recruiting - verified June 2017

  • Condition:   PTSD and Alcohol Use Disorder
    Interventions:   Drug: topiramate;   Behavioral: prolonged exposure;   Drug: placebo
    Sponsors:   VA Office of Research and Development;   University of California, San Diego
    Not yet recruiting - verified June 2017

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Apremilast;   Drug: Placebo
    Sponsors:   The Scripps Research Institute;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting - verified August 2017

  • Conditions:   Smoking;   Heavy Episodic Drinking
    Interventions:   Behavioral: Tobacco Status Project Intervention;   Behavioral: Tobacco Status Project + Alcohol Intervention;   Drug: nicotine patch
    Sponsors:   University of California, San Francisco;   National Institute on Drug Abuse (NIDA)
    Not yet recruiting - verified July 2017

  • Condition:   Unhealthy Alcohol Use
    Interventions:   Behavioral: Contingency Management Counseling;   Behavioral: Addiction Physician Management;   Behavioral: Motivational Enhancement Therapy
    Sponsors:   Yale University;   VA Connecticut Healthcare System;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting - verified August 2017

  • Condition:   Severe Alcoholic Hepatitis
    Interventions:   Drug: GS-4997;   Drug: Prednisolone;   Device: HepQuant SHUNT Test;   Drug: Placebo
    Sponsor:   HepQuant, LLC
    Recruiting - verified March 2017

  • Conditions:   Alcohol Use Disorder;   PTSD;   Cognitive Dysfunction
    Interventions:   Behavioral: Cognitive Training;   Behavioral: Cognitive training placebo control
    Sponsor:   VA Office of Research and Development
    Recruiting - verified March 2017

  • Conditions:   Sexual Behavior;   Alcohol Consumption;   Sexually Transmitted Diseases
    Interventions:   Behavioral: Knowledge alone;   Behavioral: Self-efficacy alone;   Behavioral: Perceived benefits alone;   Behavioral: Perceived benefits and self-efficacy;   Behavioral: Injunctive norms;   Behavioral: Injunctive norms and self-efficacy;   Behavioral: Injunctive norms and perceived benefits;   Behavioral: Injunctive norms, perceived benefits, and self-efficacy;   Behavioral: Descriptive norms alone;   Behavioral: Descriptive norms and self-efficacy;   Behavioral: Descriptive norms and perceived benefits;   Behavioral: Descriptive norms,perceived benefits,self-efficacy;   Behavioral: Descriptive and injunctive norms;   Behavioral: Descriptive norms, injunctive norms,self-efficacy;   Behavioral: Descriptive and injunctive norms, benefits;   Behavioral: Descriptive and injunctive norms, benefits,efficacy;   Behavioral: Expectancies alone;   Behavioral: Expectancies and self-efficacy;   Behavioral: Expectancies and Perceived Benefits;   Behavioral: Expectancies, perceived benefits, self-efficacy;   Behavioral: Expectancies and injunctive norms;   Behavioral: Expectancies, injunctive norms, and self-efficacy;   Behavioral: Expectancies, injunctive norms, benefits;   Behavioral: Expectancies, injunctive norms, benefits, efficacy;   Behavioral: Expectancies and descriptive norms;   Behavioral: Expectancies, descriptive norms, and self-efficacy;   Behavioral: Expectancies, descriptive norms, and benefits;   Behavioral: Expectancies,descriptive norms, benefits, efficacy;   Behavioral: Expectancies, descriptive and injunctive norms;   Behavioral: Expectancies, descr& injun norms, efficacy;   Behavioral: Expectancies, desc & injun norms, benefits;   Behavioral: Expectancies,desc & injun norms,benefits,efficacy
    Sponsors:   Penn State University;   University of North Carolina, Greensboro
    Recruiting - verified March 2017

  • Condition:   Alcoholic Hepatitis (AH)
    Interventions:   Drug: Selonsertib;   Drug: Prednisolone;   Drug: Placebo
    Sponsor:   Gilead Sciences
    Recruiting - verified July 2017

  • Condition:   Acute Alcoholic Hepatitis
    Interventions:   Biological: ELAD System;   Other: Standard of Care (Control)
    Sponsor:   Vital Therapies, Inc.
    Recruiting - verified August 2017

  • Conditions:   Alcohol Use;   Marijuana Use
    Interventions:   Behavioral: MICUNAY;   Other: Community Wellness Gathering
    Sponsors:   RAND;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   National Institute on Drug Abuse (NIDA);   University of California, Los Angeles;   Sacred Path Indigenous Wellness Center
    Recruiting - verified May 2017

  • Conditions:   Alcohol Dependence;   Alcohol Use Disorders;   Alcohol Abuse;   Alcoholism
    Interventions:   Drug: Mifepristone 1200 mg daily;   Behavioral: Standardized behavioral therapy;   Drug: Mifepristone 600 mg daily;   Drug: Placebo
    Sponsors:   The Scripps Research Institute;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified April 2017

  • Conditions:   Hepatitis C;   Alcohol Abuse
    Interventions:   Other: Web-Based Brief Alcohol Intervention;   Other: Usual Care
    Sponsor:   VA Office of Research and Development
    Recruiting - verified August 2017

  • Condition:   Alcohol Dependence
    Intervention:   Drug: citalopram
    Sponsor:   VA Office of Research and Development
    Recruiting - verified March 2017

  • Conditions:   Alcohol Dependence;   Nicotine Dependence
    Interventions:   Drug: Topiramate with brief behavioral enhancement therapy;   Drug: Placebo with brief behavioral enhancement therapy
    Sponsors:   University of Virginia;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   M.D. Anderson Cancer Center;   University of California, San Diego
    Recruiting - verified March 2017